11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

Size: px
Start display at page:

Download "11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?"

Transcription

1 Where Can I Find A Copy of the PDMP Law? Alabama Uniform Controlled Substances Act Code of Alabama (Article 10) -210 through 220 and Rules through.13 1 Why Was the Law Established? Hydrocodone is the most frequently prescribed opioid in the US and is associated with more abuse than any other licit or illicit opioid An unintentional drug overdose death occurs every minutes in the US (41,340 in 2011) Of these 41,340 unintentional deaths, 22,810 (55.2%) were attributed to prescription drugs Of the 22,810 deaths attributed to prescription drugs, 16,917 (76.3%) were due to opioids Prescription drug abuse is the fastest growing drug problem in the US 2 Why Was the Law Established? In 2009, for the first time, drug induced deaths exceeded deaths due to MVAs Suicide Firearms Homicide 3 1

2 Number of Deaths in Thousands /11/2015 Why Was the Law Established? Alabama has the highest number of painkiller prescriptions per year in the US at 143 Rxs per 100 people (tied with TN) (Hawaii = 52) 4 Why Was the Law Established? The US accounts for 5 % of the world s population The US accounts for 99.3% of the world s hydrocodone use at 79,700kg/yr (Next closest is the UK at 200kg/yr) 5 Drug-Poisoning Deaths Involving Opioid Analgesics or Heroin in the US, Heroin Opiods '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 '13 U.S. Drug Enforcement Administration 6 Date Prepared/Source: 01/28/15, CDC/NCHS, National Vital Statistics System, Mortality File Year Office of Diversion Control 2

3 When Was the Law Established? The Act became effective August 1, 2004 It authorized the Alabama Department of Public Health to establish a controlled substance database for the collection of controlled substances prescription data All information in the database is declared privileged and confidential Information in the database is not subject to subpoena or discovery in civil proceedings It is to be used only for investigatory or evidentiary purposes. 7 How Many Other States Use PDMP? As of 7/29/ States had operational PDMPs 2 States/District had enacted legislation, but not yet operational (NH, DC) 1 State had no legislation pending (MO) 8 What are the goals of the PDMP? To provide a source of information for practitioners and pharmacists regarding the controlled substance usage of a patient To reduce prescription drug abuse by providers and patients To reduce time and effort to explore leads as assess the merits of possible drug diversion cases, and To educate physicians, pharmacists, policy makers, law enforcement, and the public regarding diversion, abuse, and misuse of controlled substances 9 3

4 What Does the PDMP Law Require? All dispensers of controlled substances in Alabama are required to report to the PDMP except methadone clinics (exempted by federal law) and federal facilities. Dispensers include pharmacies, veterinarians, physicians, other practitioners licensed by an Alabama regulatory board. The definition of dispensing is going out the door with or to the patient. Does not include a controlled substance administered to a patient while in the practitioner s office or in a hospital. 10 What Does the PDMP Law Require? The law requires dispensers of controlled substances to report at least daily when the dispensing facility is open. Exception: Veterinarians must report at least monthly. Must report according to ASAP standards. If the dispenser does not have dispensing software, reporting can be done via an on-line account (contact PDMP Help Desk at ). If no controlled substances are dispensed a Zero report must be submitted daily (business days). The Board of Pharmacy and Board of Medical Examiners receive a list of their licensees who are not reporting or under reporting. 11 Daily Reporting Is Required As of November 2014, dispensers have been required to report daily (business days) (Exception: Veterinarians may report monthly) 12 4

5 Daily Reporting Why is Daily Reporting Better Than Weekly? The information is available sooner to be used by pharmacists and physicians as they access the information! 13 What Is Expected by The Board of Pharmacy? The responsibility for the proper prescribing and dispensing of controlled substances is upon the practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription. 21 CFR (a) U.S. v. Hayes 595 F.2d 258 (5 th Cir 1979) U.S. v. Leal 75 F. 3d 219 (6 th Cir 1996) U.S. v. Birbragher 603 F. 3d 478 (8 th Cir 2010) East Main Street Pharmacy 75 Fed. Reg (Oct. 27, 2010) 14 What Is Expected by The Board of Pharmacy? Keep your controlled substance certificate information up-to-date with the Board Accurately report controlled substance dispensing information to the database on a daily basis Use your DEA number, not your NABP or NPI number, for reporting! You must send the report, even if your volume is zero Interact as needed with prescribers 15 5

6 How Can I utilize the Information In The Database? Physicians: When you have a patient encounter and you suspect that abuse is likely, you should access the database. Pharmacists: When you are presented with a prescription and you suspect that abuse is likely, you should access the database. You must have a legitimate reason to access the database! 16 Is there Anything I Should Not Do with the Data? If you intentionally make an unauthorized disclosure of information contained in the database, you shall be guilty of a Class A misdemeanor. If you intentionally obtain unauthorized access to or you alter or destroy information contained in the database, you shall be guilty of a Class C felony. (Act , p. 781, 7.) Reports generated from the database contain confidential information, including patient identifiers, and are not public records. The information should not be provided to any other persons or entity. The information can be discussed with other healthcare professionals on a patient-specific basis when needed 17 Who May Access the Database For Cause? Certifying boards. State licensed practitioners. State licensed pharmacists. State licensed physician assistants. State, local, and federal law enforcement authorities (employed in the state). State licensed certified nurse practitioners. State licensed nurse midwives. Medicaid Agency (for Medicaid recipients only). Physician delegates. 18 6

7 Report Disclaimer No Warrant Is Made As To the Accuracy of the Information The information is based on data provided by the dispensing entities. For questions or for more information about any prescription, please contact the dispenser or the prescriber. The report contains confidential information, including patient identifiers, and is not a public record. The information should not be provided to any other persons or entity, including the patient. 19 What Happens with the Reports? A list of pharmacies not reporting or under-reporting to the database is given to the Board of Pharmacy at least every 6 months. A list of dispensing physicians who do not report is given to the Board of Medical examiners at least every 6 months. Drug Utilization Review letters to prescribers and dispensers whose patient has visited 6 or more prescribers or dispensers in one month. 20 Why Is It Important to Enter the Correct Prescriber's DEA Number and Patient Demographics? Information entered into the database is used downstream for many purposes Physicians access it Pharmacists access it Law Enforcement accesses it Incorrect information leads to confusion, duplication, and loss of confidence in the Program to accomplish its goals! 21 7

8 For additional help, call the PDMP Technical Support Desk at

NC General Statutes - Chapter 90 Article 5E 1

NC General Statutes - Chapter 90 Article 5E 1 Article 5E. North Carolina Controlled Substances Reporting System Act. 90-113.70. Short title. This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System

More information

Prescription Drug Monitoring Program

Prescription Drug Monitoring Program California Department of Justice Prescription Drug Monitoring Program May, 2016 Health and Safety Code section 11165. (a) To assist health care practitioners in their efforts to ensure appropriate prescribing,

More information

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 1 Presenter Andrea Magermans Program Analyst of the Wisconsin PDMP Wisconsin Department of Safety and Professional

More information

Prescription Drug Abuse National Perspective

Prescription Drug Abuse National Perspective Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs

More information

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Sorin Buga, MD Associate Clinical Professor Department of Supportive Care City of Hope National Medical Center SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Click to edit Master Presentation Date Disclosure

More information

COLORADO PRESCRIPTION DRUG MONITORING PROGRAM

COLORADO PRESCRIPTION DRUG MONITORING PROGRAM COLORADO PRESCRIPTION DRUG MONITORING PROGRAM Harold Rogers Prescription Drug Monitoring Program West Regional Meeting Salt Lake City, Utah August 12 13, 2014 Tia Stakely, M.S. PDMP Administrator 2005

More information

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program Arkansas Prescription Monitoring Program FY 2017 Second Quarter Report October December 2016 Arkansas Prescription Monitoring Program Quarterly Report October December, Fiscal year 2017 Act 304 of 2011

More information

Controlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control

Controlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control Controlled Substance Prescribing and Diversion Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control In 2010, approximately 38,329 unintentional drug overdose deaths occurred in the United States,

More information

Medicare Advantage Outreach and Education Bulletin

Medicare Advantage Outreach and Education Bulletin Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain

More information

Arkansas Department of Health

Arkansas Department of Health Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer

More information

MARYLAND BOARD OF PHARMACY

MARYLAND BOARD OF PHARMACY MARYLAND BOARD OF PHARMACY CONTRACEPTION REGULATIONSAnd Other Legislative Initiatives THE ROAD FROM CONCEPTUALIZATION TO IMPLEMENTATION Deena Speights-Napata Executive Director Maryland Board of Pharmacy

More information

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program Arkansas Prescription Monitoring Program FY 2016 Third Quarter Report January-March 2016 Arkansas Prescription Monitoring Program Quarterly Report January March, Fiscal year 2016 Act 304 of 2011 authorized

More information

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Presented to Bureau of Justice Assistance Harold Rogers Prescription

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin. The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp

More information

New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) PDMP West Regional Meeting PMP Collaboration with the NM Department of Health April 26, 2018 New Mexico Board of Pharmacy Prescription

More information

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid

More information

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP State, District, or Territory Alabama Arizona Arkansas Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate, the applicant shall have a current

More information

Michael M. Miller, MD, FASAM, FAPA

Michael M. Miller, MD, FASAM, FAPA Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical

More information

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid

More information

ACCG Mental Health Summit

ACCG Mental Health Summit ACCG Mental Health Summit Sheila Pierce, Opioid Program Coordinator Director, Prescription Drug Management Program Discussion 1. Overview Opioid Problem in GA - Video 2. DPH Opioid Program 3. Priorities

More information

North Dakota Board of Pharmacy

North Dakota Board of Pharmacy North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives

More information

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust Addressing Prescription Drug Abuse Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust Outline 1. Prescription Drug Monitoring Programs 2. Federal policy landscape including

More information

Model State Electronic Prescription Monitoring Program Legislation

Model State Electronic Prescription Monitoring Program Legislation Model State Electronic Prescription Monitoring Program Legislation Produced by the University of Wisconsin s Pain & Policy Studies Group (PPSG) in partnership with the American Cancer Society Cancer Action

More information

Opioids drive continued increase in drug overdose deaths

Opioids drive continued increase in drug overdose deaths CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th

More information

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin

More information

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

On December 27, 2017, the Lieutenant Governor signed into law several new requirements OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following

More information

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Mark W. Parrino, M.P.A. July 21, 2018 15 th Annual Midwest Conference on Problem Gambling and Substance Abuse Hilton Kansas

More information

Michigan Automated Prescription System

Michigan Automated Prescription System MAPS Michigan Automated Prescription System Accuracy of Data Edits applied. Most at 95% Two full time technicians. Two part time students. Full time analyst One shared tech and PT programmer. Data uploads

More information

The Wisconsin Prescription Drug Monitoring Program

The Wisconsin Prescription Drug Monitoring Program The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing

More information

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services

More information

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017 Prescription Drug Monitoring Program (PDMP) Delaware Information contained in this presentation is accurate as of November 2017 Dr. Michael C. Dejos, PharmD, BCPS, LSSBB 2 Acknowledgements Christian Ruffin,

More information

Unintentional Poisonings: Public Health Response Joint Legislative Health Care Oversight Committee

Unintentional Poisonings: Public Health Response Joint Legislative Health Care Oversight Committee Unintentional Poisonings: Public Health Response Joint Legislative Health Care Oversight Committee Dr. Ruth Petersen Chronic Disease and Injury Section Division of Public Health Oct 12, 2010 In 1999, the

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for

More information

Confronting the Opioid Epidemic

Confronting the Opioid Epidemic Confronting the Opioid Epidemic Appropriately Treating Pain while Stopping Abuse Scott Kennedy, MD, Chief Medical Officer, Olympic Medical Center Ian Corbridge, RN, Clinical Policy Director, WSHA June

More information

A Bill Regular Session, 2015 SENATE BILL 717

A Bill Regular Session, 2015 SENATE BILL 717 Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas 0th General Assembly As Engrossed: S// H// A Bill Regular Session, SENATE BILL By: Senator

More information

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response Reducing Opioid Deaths: Arizona s Emergency Declaration & Response September 15, 2017 Sheila Sjolander, Assistant Director Arizona Department of Health Services Emergency Declaration On June 5, 2017, Arizona

More information

Although PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.

Although PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states. NASCSA Statement for the Record as presented by Barbara A Carter, President, NASCSA Submitted to: Department of Health and Human Services, Food and Drug Administration, Opioid Policy Steering Committee

More information

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,

More information

Medicare Advantage Outreach and Education Bulletin

Medicare Advantage Outreach and Education Bulletin Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross and Blue Shield Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management.

More information

Review of Controlled Drugs and Substances Act

Review of Controlled Drugs and Substances Act Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A

More information

Washington State PMP Data Mapping Project

Washington State PMP Data Mapping Project Washington State PMP Data Mapping Project 2014 Category 3 Grant Harold Rogers Category 3 Grantee Meeting February 25, 2015 Washington State BACKGROUND: OPIOID ISSUES AND PLANNING 2 WA Unintentional Opioid

More information

SCRIPTS. South Carolina Reporting & Identification Prescription Tracking System

SCRIPTS. South Carolina Reporting & Identification Prescription Tracking System SCRIPTS South Carolina Reporting & Identification Prescription Tracking System Accidental Deaths 3 Due to Drug Overdose SC Occurrence Data Accidental Drug Overdose Year # of Deaths All deaths Drug not

More information

Referred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada.

Referred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada. S.B. SENATE BILL NO. COMMITTEE ON HEALTH AND HUMAN SERVICES (ON BEHALF OF THE GOVERNOR) MARCH, 0 Referred to Committee on Health and Human Services SUMMARY Establishes an opioid overdose prevention policy

More information

CDC s Approach to Addressing the Opioid Overdose Epidemic

CDC s Approach to Addressing the Opioid Overdose Epidemic CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths

More information

BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director

BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director BOARD OF PHARMACY- REGULATORY UPDATE Kimberly Grinston, J.D., Executive Director Disclosure and Conflict of Interest I declare no conflicts of interest, real or apparent, and no financial interest in any

More information

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. Arizona Corporate Counsel Presentation May 8, 2018 Agenda 1. Overview of the Opioid

More information

UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB)

UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB) UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB) Harold Rogers Prescription Drug Monitoring Program National Meeting Washington, D.C. August 17 August 19 th, 2016 Marvin H. Sims, C.S. DataBase Administrator

More information

Michigan Opioid Legislation Hospital Compliance Checklist

Michigan Opioid Legislation Hospital Compliance Checklist MHA KEYSTONE CENTER MICHIGAN OPIOID LEGISLATION HOSPITAL COMPLIANCE CHECKLIST The Michigan Opioid Legislation was created by the Michigan Health & Hospital Association to help guide its member hospitals

More information

North Carolina, like the rest of the nation, has been experiencing

North Carolina, like the rest of the nation, has been experiencing INVITED COMMENTARY The North Carolina Controlled Substances Reporting System: A Valuable Tool for Combating Prescription Drug Misuse William D. Bronson Prescription drug misuse is a growing problem that

More information

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE

More information

Presentation Overview

Presentation Overview Navigating the Changing Regulatory Enforcement Landscape Relating to Opioids Anna M. Grizzle Tizgel K.S. High Jerry Williamson, M.D. Presentation Overview Recent Enforcement Actions Physician s Perspective

More information

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Fraud and Compliance Forum, October 2017. Click here to access audio. AHLA X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Michelle Bergholz Frazier Senior Vice President,

More information

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Alabama Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance of more than 30 MME per day, physicians shall query the PMP for that patient at least

More information

The Role of the PDMP: Foundational Knowledge and Best Practices

The Role of the PDMP: Foundational Knowledge and Best Practices The Role of the PDMP: Foundational Knowledge and Best Practices Brent I. Fox, PharmD, PhD Health Outcomes Research and Policy Harrison School of Pharmacy Auburn University DISCLOSURE I, Brent Fox, have

More information

Preventing Opioid Misuse in Texas

Preventing Opioid Misuse in Texas Preventing Opioid Misuse in Texas Kasey Strey, ACPS, SPF-Rx Project Director Jessica Duncan Cance, MPH, PhD, TTOR Lead Purpose Provide an overview of HHSC -funded opioid misuse prevention activities Discuss

More information

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement. NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau

More information

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors This educational call is sponsored by the Enterprise Risk Management Task Force. Thursday, April 11, 2013 11:00 am 12:00

More information

An Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER)

An Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER) An Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER) Mary Reinle Begley Inspector General Kentucky David R. Hopkins KASPER Program Manager Office of Inspector General Health Care

More information

SIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2017 GENERAL SESSION

SIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2017 GENERAL SESSION AN ACT relating to public health and safety; creating the Emergency Administration of Opiate Antagonist Act; providing for prescription and administration of an opiate antagonist drug as specified; granting

More information

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q) Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and

More information

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3) NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 218 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau

More information

2013 DEA REGULATORY ENFORCEMENT UPDATE

2013 DEA REGULATORY ENFORCEMENT UPDATE 2013 DEA REGULATORY ENFORCEMENT UPDATE Ronald J. Friedman, JD Lane Powell, PC - Seattle CHARACTERIZING DEA ACTION IN 2012-13 CONTINUED FOCUS & PREOCCUPATION WITH PRESCRIPTION DRUG ABUSE USING AS A THEME

More information

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0 1 HB37 2 188862-1 3 By Representative Williams (JD) 4 RFD: Health 5 First Read: 09-JAN-18 6 PFD: 11/28/2017 Page 0 1 188862-1:n:11/16/2017:PMG/tj LSA2017-3516 2 3 4 5 6 7 8 SYNOPSIS: This bill would establish

More information

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D. MAPS Update May 4, 2018 Presented by Kim Gaedeke, Acting Deputy Director Department of Licensing and Regulatory Affairs Andrew Hudson, Manager Drug Monitoring Section BPL-MAPS@Michigan.gov 517-373-1737

More information

PROPOSED AMENDMENTS TO HOUSE BILL 3440

PROPOSED AMENDMENTS TO HOUSE BILL 3440 HB 0- (LC ) // (MBM/ps) Requested by Representative WILLIAMSON PROPOSED AMENDMENTS TO HOUSE BILL 0 1 On page 1 of the printed bill, line, delete 1A. and. Delete lines through and pages through and insert:

More information

The Opioid Epidemic: The State of the State

The Opioid Epidemic: The State of the State JOINT LEGISLATIVE COMMITTEE ON HEALTH AND HUMAN SERVICES The Opioid Epidemic: The State of the State Dr. Mandy Cohen, Dr. Susan Kansagra Department of Health and Human Services Nov. 14, 2017 3 PEOPLE DIE

More information

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)

More information

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Kentucky All Schedule Prescription Electronic Reporting (KASPER) Kentucky All Schedule Prescription Electronic Reporting (KASPER) Phyllis Millspaugh Manager, Behavioral Health Prevention and Promotion Kentucky Cabinet for Health and Family Services Using PDMP Data to

More information

SENATE FILE NO. SF0042. Sponsored by: Joint Judiciary Interim Committee A BILL. for. AN ACT relating to public health and safety; creating the

SENATE FILE NO. SF0042. Sponsored by: Joint Judiciary Interim Committee A BILL. for. AN ACT relating to public health and safety; creating the 0 STATE OF WYOMING LSO-000 SENATE FILE NO. SF00 Opiate overdose emergency treatment. Sponsored by: Joint Judiciary Interim Committee A BILL for AN ACT relating to public health and safety; creating the

More information

9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort

9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort DEA FIELD OFFICES IN FLORIDA Miami Divisional Office David Wickey, GS 954-306-4650 Orlando District Office Linda Stocum, GS 407-333-7046 Tampa District Office Amie Hickerson, GS 813-287-5160 Tallahassee/Jacksonville

More information

Potential Solutions to Epidemic Substance Abuse in US and Europe

Potential Solutions to Epidemic Substance Abuse in US and Europe Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine

More information

New Policy Changes Designed to Combat the Opioid Epidemic

New Policy Changes Designed to Combat the Opioid Epidemic New Policy Changes Designed to Combat the Opioid Epidemic Alan W. Obringer, RPh, CPh, CGP President of Guardian Pharmacy of Orlando and Brad Kile, PhD President of Dumbarton Group, LLC Objectives List

More information

PDMP Tools to Identify Red Flag Situations

PDMP Tools to Identify Red Flag Situations PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management

More information

Do not open the test booklet prior to being told to do so.

Do not open the test booklet prior to being told to do so. Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources

More information

PRESCRIPTION DRUG MONITORING PROGRAM

PRESCRIPTION DRUG MONITORING PROGRAM PRESCRIPTION DRUG MONITORING PROGRAM ST. LOUIS COUNTY Q2 2017 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6 Dispensation

More information

Prescription Drugs: Issues in Treatment, Supervision and Case Management

Prescription Drugs: Issues in Treatment, Supervision and Case Management Prescription Drugs: Issues in Treatment, Supervision and Case Management National Association of Drug Court Professionals Washington, DC July 16, 2013 Agenda Overview of prescription drug diversion and

More information

ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ]

ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ] TITLE 16 CHAPTER 19 PART 26 OCCUPATIONAL AND PROFESSIONAL LICENSING PHARMACISTS PHARMACIST PRESCRIPTIVE AUTHORITY 16.19.26.1 ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque,

More information

Strategies to Manage The Opioid Crisis

Strategies to Manage The Opioid Crisis Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor

More information

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services Helping People Live Better Lives Background DHHS dynamic agency Helping

More information

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016 1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5

More information

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System Our Journey to Addressing the PA PDMP Program Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System 1 Geisinger Health System Geisinger Health System is an integrated

More information

State, District, or Territory Criteria for Mandatory Query of PDMP

State, District, or Territory Criteria for Mandatory Query of PDMP State, District, or Territory Alabama Alaska Arizona Criteria for Mandatory Query of PDMP Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance

More information

Presentation Objectives

Presentation Objectives Oregon s PDMP 101 Lisa Millet, MSH, Section Manager Injury and Violence Prevention Section Center for Prevention and Health Promotion Oregon Health Authority Eugene Oregon PDO Summit April 20, 2016 1 Presentation

More information

Evaluation of the N.C. Prescription

Evaluation of the N.C. Prescription Evaluation of the N.C. Prescription Drug Monitoring Program 2013 National Meeting of the Safe States Alliance and SAVIR MarianaGarrettson Garrettson, MPH Chris Ringwalt, DrPH UNC Injury Prevention Research

More information

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being

More information

Ontario s Narcotics Strategy

Ontario s Narcotics Strategy Ontario s Narcotics Strategy Ontario Public Drug Programs Ministry of Health and Long-Term Care January 31, 2012 Ontario Harm Reduction Distribution Program Conference 2012 1 Background The Need for Action

More information

Oregon Prescription Drug Monitoring Program

Oregon Prescription Drug Monitoring Program Oregon Prescription Drug Monitoring Program 2013 Annual Report to the PDMP Advisory Commission PUBLIC HEALTH DIVISION Prescription Drug Monitoring Program Oregon Prescription Drug Monitoring Program 2013

More information

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP THA Medication Safety Summit Wesley Geminn, PharmD, BCPP Current Trends: Overdose Deaths in 2017 72,000 Or 197 per day 8 per hour National Opioid Overdose Statistics https://www.drugabuse.gov/related-topics/trendsstatistics/overdose-death-rates

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices

Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices August 25, 2017 Presented by Michael Crooks, PharmD. Medication Safety and Care Coordination Task Lead 8/28/2017

More information

Prescription Opioid Overdose in Oregon: A public health perspective

Prescription Opioid Overdose in Oregon: A public health perspective Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,

More information

Mark W. Caverly, Chief Liaison and Policy Section

Mark W. Caverly, Chief Liaison and Policy Section DEA Issues: An Update Harold Rogers National Prescription Drug Monitoring Meeting Meeting September 24 25, 2009 Mark W. Caverly, Chief Liaison and Policy Section Prescription Drug Abuse Prescription Drug

More information

btute PUBLIC CHAPTER NO. 1039

btute PUBLIC CHAPTER NO. 1039 btute of @ennennee PUBLIC CHAPTER NO. 1039 HOUSE BILL NO. 1831 By Representatives Hawk, Gasada, Kumar, Johnson, Gameron Sexton, Terry, Powers, Coley, Daniel, Eldridge, Holsclaw, Favors, Hardaway Substituted

More information

Prescription Drug Monitoring Program (PDMP)

Prescription Drug Monitoring Program (PDMP) Prescription Drug Monitoring Program (PDMP) District of Columbia Information contained in this presentation is accurate as of September 2017 Meet the Speaker Tadessa Harper-Nichols Program Specialist Pharmaceutical

More information

REPORTING OF POISONINGS DUE TO THE USE OF PRESCRIPTION OR ILLICIT DRUGS Frequently Asked Questions on Emergency Rules. 1/2/2019 Revision Date

REPORTING OF POISONINGS DUE TO THE USE OF PRESCRIPTION OR ILLICIT DRUGS Frequently Asked Questions on Emergency Rules. 1/2/2019 Revision Date REPORTING OF POISONINGS DUE TO THE USE OF PRESCRIPTION OR ILLICIT DRUGS Frequently Asked Questions on Emergency Rules 1/2/2019 Revision Date Why is the rule needed? The emergency rules are promulgated

More information